Development and validation of a semi-automated hybrid immunocapture liquid chromatography-mass spectrometry method to quantify LALA-mutated biotherapeutics in mouse plasma

Authors: Vittoria Papa, Ilse De Salve, Francesco Molinaro et al.
Publication: European Journal of Pharmaceutical Sciences
Published: Aug 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

A Simplified Approach to Evaluate Retinal Blue Light Hazard Using the Correlated Color Temperature of LED Light Sources

Farough Mohammadian, Ahmad Mehri et al. - Oct 2121

Read More
The Development of Loyalty with Online Services Customers

Apostolos Giovanis - Jan 2117

Read More
Corporate Social Responsibility: A marketing tool and/or a factor for the promotion of sustainable development for companies? An empirical examination of listed companies in the Athens Stock Exchange

Olga Helen Astara, Roldo Mitoula et al. - Apr 2115

Read More
Validation of the Meaning in Life Questionnaire (MLQ) in Chinese University Students and Invariance across Gender

Unknown - Jan 2106

Read More
Peri-Urban Food Futures: Opportunities and Challenges to Reconfiguring Sustainable Local Agri-food Value Chains on the Sunshine Coast, Australia

Brian Stockwell, Elaine Bradley et al. - Nov 2103

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0